These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37559520)

  • 21. Bowel-associated dermatosis - arthritis syndrome in a patient with ulcerative colitis: an extraintestinal manifestation of inflammatory bowel disease.
    DeFilippis EM; Magro C; Jorizzo JL
    Clin J Gastroenterol; 2014 Oct; 7(5):410-3. PubMed ID: 26184020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A GP guide to inflammatory bowel disease.
    Langmead L; Rampton D
    Practitioner; 2001 Mar; 245(1620):224-9. PubMed ID: 11258190
    [No Abstract]   [Full Text] [Related]  

  • 23. Tissue IgG4-positive plasma cells in inflammatory bowel disease: a study of 88 treatment-naive biopsies of inflammatory bowel disease.
    Virk R; Shinagare S; Lauwers GY; Yajnik V; Stone JH; Deshpande V
    Mod Pathol; 2014 Mar; 27(3):454-9. PubMed ID: 23929268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory bowel disease and the elderly: a review.
    Taleban S; Colombel JF; Mohler MJ; Fain MJ
    J Crohns Colitis; 2015 Jun; 9(6):507-15. PubMed ID: 25870198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of inflammatory bowel disease with methotrexate in clinical practice.
    Magalhães RK; Lago P; Pedroto I
    J Crohns Colitis; 2013 Dec; 7(11):e606. PubMed ID: 23871412
    [No Abstract]   [Full Text] [Related]  

  • 26. Biologics in Pediatric Inflammatory Bowel Disease.
    Kleinhenz J; Wagner E
    Pediatr Ann; 2022 Feb; 51(2):e77-e81. PubMed ID: 35156888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treat-to-Target in Inflammatory Bowel Diseases, What Is the Target and How Do We Treat?
    Agrawal M; Colombel JF
    Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):421-436. PubMed ID: 31078245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease phenotype and outcomes of very early-onset inflammatory bowel disease.
    Dipasquale V; Lo Presti G; Romano C
    Eur J Intern Med; 2022 Aug; 102():138-139. PubMed ID: 35534375
    [No Abstract]   [Full Text] [Related]  

  • 29. [4th Congress of ECCO (5-7 February 2009, Hamburg (Germany). (The European Crohn's and Colitis Organization)--Inflammatory bowel diseases 2009)].
    Baryshnikov EN; Kniazev OV
    Eksp Klin Gastroenterol; 2009; (3):158-60. PubMed ID: 19928013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role.
    Hertervig E; Wieslander J; Johansson C; Wiik A; Nilsson A
    Scand J Gastroenterol; 1995 Jul; 30(7):693-8. PubMed ID: 7481534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical differences between elderly-onset ulcerative colitis and non-elderly-onset ulcerative colitis: A nationwide survey data in Japan.
    Komoto S; Higashiyama M; Watanabe C; Suzuki Y; Watanabe M; Hibi T; Takebayashi T; Asakura K; Nishiwaki Y; Miura S; Hokari R
    J Gastroenterol Hepatol; 2018 Nov; 33(11):1839-1843. PubMed ID: 29669163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comorbidities Rather Than Age Are Associated With the Use of Immunomodulators in Elderly-onset Inflammatory Bowel Disease.
    Kariyawasam VC; Kim S; Mourad FH; Selinger CP; Katelaris PH; Brian Jones D; McDonald C; Barr G; Chapman G; Colliwshaw J; Lunney PC; Middleton K; Wang RR; Huang T; Andrews J; Pathirana PW; Leong RW
    Inflamm Bowel Dis; 2019 Jul; 25(8):1390-1398. PubMed ID: 30597066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct Entity of Inflammatory Bowel Disease in Autoimmune Sclerosing Cholangitis.
    Li H; Shu H; Tian F
    Inflamm Bowel Dis; 2021 Oct; 27(10):e125-e127. PubMed ID: 34042160
    [No Abstract]   [Full Text] [Related]  

  • 34. Inflammatory bowel disease in the elderly. Practical treatment guidelines.
    Akerkar GA; Peppercorn MA
    Drugs Aging; 1997 Mar; 10(3):199-208. PubMed ID: 9108893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities.
    Plevris N; Lees CW
    Gastroenterology; 2022 Apr; 162(5):1456-1475.e1. PubMed ID: 35101422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in inflammatory bowel diseases in children.
    Michail S; Ramsy M; Soliman E
    Minerva Pediatr; 2012 Jun; 64(3):257-70. PubMed ID: 22555319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current issues in pediatric inflammatory bowel disease-associated arthropathies.
    Cardile S; Romano C
    World J Gastroenterol; 2014 Jan; 20(1):45-52. PubMed ID: 24415857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JAK Inhibition as a Therapeutic Strategy for Inflammatory Bowel Disease.
    Macaluso FS; Rodríguez-Lago I
    Curr Drug Metab; 2020; 21(4):247-255. PubMed ID: 32156234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Very early onset inflammatory bowel disease: Spectrum of clinical presentation, diagnostic tools and outcome in children.
    Cheema HA; Waheed N; Saeed A; Fayyaz Z; Anjum MN; Alvi MA; Batool SS
    J Pak Med Assoc; 2021 Oct; 71(10):2350-2354. PubMed ID: 34974569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosticating the Course of Inflammatory Bowel Disease.
    Koliani-Pace JL; Siegel CA
    Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):395-404. PubMed ID: 31078243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.